p38 Inhibitor SB203580 sensitizes the resveratrol-induced apoptosis in human lung adenocarcinoma (A549) cells

被引:4
|
作者
Li, Haiyang [1 ]
Wang, Xiaoping [1 ]
Chen, Tongsheng [2 ,3 ]
Qu, Junle [4 ]
机构
[1] Jinan Univ, Affiliated Hosp 1, Dept Anesthesiol, Guangzhou 510632, Guangdong, Peoples R China
[2] S China Normal Univ, Coll Biophoton, Inst Laser Life Sci, Guangzhou 510631, Guangdong, Peoples R China
[3] S China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou 510631, Guangdong, Peoples R China
[4] Shenzhen Univ, Inst Optoelect, Minist Educ & Guangdong Prov, Key Lab Optoelect Devices & Syst, Shenzhen 518060, Peoples R China
基金
中国国家自然科学基金;
关键词
Resveratrol; SB203580; A549; p38; Apoptosis; Bax; Caspase; FasL; SIGNAL-TRANSDUCTION; PROTEIN; ACTIVATION; PATHWAY; KINASE; BAX; MODULATION; SURVIVAL; MAPK;
D O I
10.1002/jbt.21413
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Based on our recent findings that resveratrol, a natural plant polyphenol found in red grape skins as well as other food products, induces apoptosis via a caspase-independent intrinsic pathway in human lung adenocarcinoma cells, this study is designed to explore whether SB203580, a p38 inhibitor, potentiates the resveratrol-induced apoptosis of human lung adenocarcinoma (A549) cells. We found that pretreatment with SB203580 enhanced the resveratrol-induced apoptosis by accelerating the intrinsic apoptotic pathway including Bax activation, loss of mitochondrial membrane potential, and activation of both caspase-9 and -3. Although treatment with resveratrol alone did not induce caspase-8 activation, cotreatment with both SB203580 and resveratrol not only enhanced FasL cleavage but also activated caspase-8, indicating that the extrinsic apoptotic pathway may be involved in the synergistic effect. Collectively, we for the first time demonstrate that SB203580 synergistically enhances the resveratrol-induced apoptosis by accelerating Bax-mediated intrinsic pathway and initiating extrinsic pathway, suggesting a possible alternative therapeutic strategy for human lung cancer. (c) 2012 Wiley Periodicals, Inc. J Biochem Mol Toxicol 26:251257, 2012; View this article online at . DOI 10.1002/jbt.21413
引用
收藏
页码:251 / 257
页数:7
相关论文
共 50 条
  • [21] The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical
    Mocanu, MM
    Baxter, GF
    Yue, Y
    Critz, SD
    Yellon, DM
    BASIC RESEARCH IN CARDIOLOGY, 2000, 95 (06) : 472 - 478
  • [22] SB203580, a p38 Inhibitor, Improved Cardiac Function but Worsened Lung Injury and Survival During Escherichia coli Pneumonia in Mice
    Su, Junwu
    Cui, Xizhong
    Li, Yan
    Mani, Haresh
    Ferreyra, Gabriela A.
    Danner, Robert L.
    Hsu, Lewis L.
    Fitz, Yvonne
    Eichacker, Peter Q.
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2010, 68 (06): : 1317 - 1327
  • [23] The p38 MAPK inhibitor SB203580 blocks adenosine A1 receptor-induced attenuation of in vivo myocardial stunning
    Yoshimura, Y
    Kristo, G
    Keith, BJ
    Jahania, SA
    Mentzer, RM
    Lasley, RD
    CARDIOVASCULAR DRUGS AND THERAPY, 2004, 18 (06) : 433 - 440
  • [24] The p38 MAPK Inhibitor SB203580 Blocks Adenosine A1 Receptor-Induced Attenuation of In Vivo Myocardial Stunning
    Yukihiro Yoshimura
    Gentian Kristo
    Byron J. Keith
    Salik A. Jahania
    Robert M. Mentzer
    Robert D. Lasley
    Cardiovascular Drugs and Therapy, 2004, 18 : 433 - 440
  • [25] Induction of autophagy in hepatocellular carcinoma cells by SB203580 requires activation of AMPK and DAPK but not p38 MAPK
    Haitao Zhang
    George G. Chen
    Zhiyi Zhang
    Sukying Chun
    Billy Cheuk Sing Leung
    Paul B. S. Lai
    Apoptosis, 2012, 17 : 325 - 334
  • [26] Inhibition of p38 mitogen-activated protein kinase-induced apoptosis in cultured mature oligodendrocytes using SB2021.90 and SB203580
    Hamanoue, Makoto
    Sato, Kenichiro
    Takamatsu, Ken
    NEUROCHEMISTRY INTERNATIONAL, 2007, 51 (01) : 16 - 24
  • [27] Induction of autophagy in hepatocellular carcinoma cells by SB203580 requires activation of AMPK and DAPK but not p38 MAPK
    Zhang, Haitao
    Chen, George G.
    Zhang, Zhiyi
    Chun, Sukying
    Leung, Billy Cheuk Sing
    Lai, Paul B. S.
    APOPTOSIS, 2012, 17 (04) : 325 - 334
  • [28] Neuroprotective effects of SB203580 (p38 MAP kinase inhibitor) against Endothelin-1-induced retinal ganglion cell death
    Krishnamoorthy, Vignesh
    He, Shaoqing
    Chaphalkar, Renuka
    Kodati, Bindu
    Krishnamoorthy, Raghu R.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [29] Effect of the p38 kinase inhibitor, SB 203580, on sephadex induced airway inflammation in the rat
    Birrell, M
    Hele, D
    McCluskie, K
    Webber, S
    Foster, M
    Belvisi, MG
    EUROPEAN RESPIRATORY JOURNAL, 2000, 16 (05) : 947 - 950
  • [30] p38 mitogen activated protein kinase inhibitor SB203580 attenuate the mechanical allodynia in neuropathic pain model.
    Mizokoshi, A
    Tsuda, M
    Shigemoto-Mogami, Y
    Koizumi, S
    Inoue, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 187P - 187P